Difficulty: Medium
Average Score: 86%
Practice
A client with Preeclampsia is receiving Magnesium Sulfate IV continuous infusion. Which of the following findings should the nurse report to the provider?
Correct answer
C
Rationale
In the context of a client with Preeclampsia receiving Magnesium Sulfate IV continuous infusion, the nurse should report a urinary output of 24 mL/hr to the provider. This finding suggests oliguria, which can indicate impaired renal function or magnesium toxicity. Magnesium sulfate is excreted by the kidneys, so a low urinary output could indicate decreased clearance of the medication, leading to potential toxicity.
Option A (2+ deep tendon reflexes) is a normal finding in a client receiving magnesium sulfate due to its neuromuscular effects. Option B (2+ pedal edema) is a common symptom in preeclampsia but is not directly related to magnesium sulfate infusion. Option D (respirations 12/min) is within the normal range and not typically a concern with magnesium sulfate infusion unless respiratory depression is present.
Educationally, understanding the importance of monitoring urinary output in clients receiving magnesium sulfate is crucial for safe and effective nursing care. It highlights the need for close assessment and communication with the healthcare provider to prevent complications associated with magnesium sulfate therapy.
Option A (2+ deep tendon reflexes) is a normal finding in a client receiving magnesium sulfate due to its neuromuscular effects. Option B (2+ pedal edema) is a common symptom in preeclampsia but is not directly related to magnesium sulfate infusion. Option D (respirations 12/min) is within the normal range and not typically a concern with magnesium sulfate infusion unless respiratory depression is present.
Educationally, understanding the importance of monitoring urinary output in clients receiving magnesium sulfate is crucial for safe and effective nursing care. It highlights the need for close assessment and communication with the healthcare provider to prevent complications associated with magnesium sulfate therapy.